Sight Sciences (SGHT) announced that UnitedHealthcare (UNH) has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty, and combined canaloplasty and trabeculotomy procedures for adults, when deemed medically necessary for treating mild to moderate open-angle glaucoma and cataract in adults currently being treated with ocular hypotensive medication. This coverage policy, effective October 1, 2025, applies to UHC’s commercial and individual exchange benefit plans. UHC is one of the largest health insurance companies in the United States with over 50 million total covered lives. The commercial and individual exchange benefits plans currently cover approximately 30 million of the over 50 million total covered lives under UHC.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
- Sight Sciences: Hold Rating Amid Workforce Reduction and Cost Management Strategy
- Sight Sciences Announces Workforce Reduction Plan
- Sight Sciences price target raised to $4.50 from $3.60 at Citi
- Sight Sciences’ Earnings Call: Balancing Growth and Challenges
- Sight Sciences upgraded to Buy from Hold at Lake Street